Free Webinar! GW-GU-SoPE Immunology and Immuno-Oncology Showcase 10/26

This virtual event presents the latest inventions in immunology and immuno-oncology from Washington DC's two R1 research universities. We hope you will join us! Wharton Club members & guests are invited!

 

1

 

 

 

 

About this event

The George Washington University (GW) Technology Commercialization Office, the Georgetown University (GU) Office of Technology Commercialization, and the Society of Physician Entrepreneurs (SoPE) are pleased to invite you to the 2022 GW-GU-SoPE Immunology and Immuno-Oncology Showcase!

GW and GU co-present with SoPE a showcase of cutting edge immunology and immuno-oncology inventions available for licensing in a virtual lunch-hour webinar.

Format: 10 minute presentations and 5 minute Q&A periods for each technology

Moderated by: Jeffrey Hausfeld, MD, MBA, Co-Founder and Chairman of SoPE, Chairman and CMO of BioFactura, Inc., President, Memory Care Communities LLC

Co-Hosts:

B´╗┐rian Coblitz, PhD, Executive Director, GW Technology Commercialization Office

Ruchika Nijhara, PhD, MBA, CLP, Vice President (Interim), GU Office of Technology Commercialization

AGENDA

12:00–12:10PM | Welcome Remarks

12:10–12:25PM | Fibroblast Activation Protein: A newly discovered motor that promotes Natural Killer Cell invasion into tumor masses | Louis Weiner, MD, Ph.D., Director of Lombardi Comprehensive Cancer Center and Professor and Chair, Department of Oncology, Georgetown University

12:25–12:40PM | A Booster of Anticancer CAR-T Immunotherapy | Rong Li, PhD, Chair and Professor of Biochemistry and Molecular Medicine, Ross Professor of Basic Science Research, The George Washington University

12:40–12:55PM | Anti-inflammatory adoptive cell therapy using macrophages pretreated with HDAC11 inhibitor | Alejandro Villagra, PhD, Associate Professor, Department of Medicine - Division of Hematology and Oncology, Georgetown University (technology available from the George Washington University)

12:55–1:10PM | A Novel Liver X Receptor (LXR) Agonist for Targeting Fibrosis to Combat Immune Tolerance and Enhance Cancer Therapy | Robert Glazer, PhD, Professor, Department of Medicine - Division of Hematology and Oncology, Georgetown University

1:10–1:25PM | Discovery of new immune cell types with significant implications in treating COVID and autoimmune diseases | Samir Khleif, MD, PhD, Professor, Department of Medicine - Division of Hematology and Oncology, Georgetown University

 

2358
Click here to reserve your place for the program

 

When:

12:00PM - 1:25PM Wed 26 Oct 2022, Eastern timezone

Virtual Event Instructions:

Zoom URL for your own use will be listed in the email you receive after you register.

 

Click here to reserve your seat(s)

for the program